s 12363 has been researched along with Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ardiet, C; Clavel, M; Ings, RM; Lelièvre, E; Leyvraz, S; Lokiec, F; Lucas, C; Minaidis, D; Solere, P; Turpin, F | 1 |
Budman, DR | 1 |
1 review(s) available for s 12363 and Neoplasms
Article | Year |
---|---|
New vinca alkaloids and related compounds.
Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Clinical Trials as Topic; Drugs, Investigational; Humans; Lactones; Macrolides; Neoplasms; Vinblastine; Vinca Alkaloids; Vinorelbine | 1992 |
1 trial(s) available for s 12363 and Neoplasms
Article | Year |
---|---|
Value of early pharmacodynamic and pharmacokinetic investigations with anticancer drugs: data from phase I tolerance studies on a new vinca alkaloid derivative.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Humans; Middle Aged; Neoplasms; Vinca Alkaloids | 1992 |